{"id":"https://openalex.org/W4389434864","doi":"https://doi.org/10.1021/acs.molpharmaceut.3c00685","title":"iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products","display_name":"iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products","publication_year":2023,"publication_date":"2023-12-07","ids":{"openalex":"https://openalex.org/W4389434864","doi":"https://doi.org/10.1021/acs.molpharmaceut.3c00685","pmid":"https://pubmed.ncbi.nlm.nih.gov/38059771","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10762654"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.3c00685","doi":"https://doi.org/10.1021/acs.molpharmaceut.3c00685","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.3c00685","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00685","source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00685","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013254567","display_name":"Jayne E. Hastedt","orcid":"https://orcid.org/0000-0002-1784-4635","observed_orcids":["https://orcid.org/0000-0002-1784-4635"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jayne E. Hastedt","raw_affiliation_strings":["JDP Pharma Consulting, San Carlos, California 94070, United States"],"raw_orcid":"https://orcid.org/0000-0002-1784-4635","affiliations":[{"raw_affiliation_string":"JDP Pharma Consulting, San Carlos, California 94070, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081409383","display_name":"Per B\u00e4ckman","orcid":"https://orcid.org/0000-0001-6210-8461","observed_orcids":["https://orcid.org/0000-0001-6210-8461"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Per B\u00e4ckman","raw_affiliation_strings":["Emmace Consulting, 223 63 Lund, Sweden"],"raw_orcid":"https://orcid.org/0000-0001-6210-8461","affiliations":[{"raw_affiliation_string":"Emmace Consulting, 223 63 Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063033406","display_name":"Antonio Cabal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Cabal","raw_affiliation_strings":["Eisai, Woodcliff Lake, New Jersey 07677, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai, Woodcliff Lake, New Jersey 07677, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andy Clark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andy Clark","raw_affiliation_strings":["Aerogen Pharma, San Mateo, California 94402, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aerogen Pharma, San Mateo, California 94402, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046196564","display_name":"Carsten Ehrhardt","orcid":"https://orcid.org/0000-0003-0730-1829","observed_orcids":["https://orcid.org/0000-0003-0730-1829"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Carsten Ehrhardt","raw_affiliation_strings":["School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin D02 PN40, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin D02 PN40, Ireland","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069886359","display_name":"Ben Forbes","orcid":"https://orcid.org/0000-0001-8193-6107","observed_orcids":["https://orcid.org/0000-0001-8193-6107"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ben Forbes","raw_affiliation_strings":["King\u2019s College London, London SE1 9NH, U.K"],"raw_orcid":"https://orcid.org/0000-0001-8193-6107","affiliations":[{"raw_affiliation_string":"King\u2019s College London, London SE1 9NH, U.K","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071846305","display_name":"Anthony James Hickey","orcid":"https://orcid.org/0000-0002-3324-9326","observed_orcids":["https://orcid.org/0000-0002-3324-9326"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony J. Hickey","raw_affiliation_strings":["RTI International, Research Triangle Park, North Carolina 27709, United States","University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI International, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I180297670"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033045204","display_name":"G\u00fcnther Hochhaus","orcid":"https://orcid.org/0000-0002-7406-5558","observed_orcids":["https://orcid.org/0000-0002-7406-5558"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guenther Hochhaus","raw_affiliation_strings":["University of Florida, Gainesville, Florida 32611, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, Florida 32611, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103049255","display_name":"Wenlei Jiang","orcid":"https://orcid.org/0009-0009-3876-638X","observed_orcids":["https://orcid.org/0009-0009-3876-638X"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenlei Jiang","raw_affiliation_strings":["Center for Drug Evaluation and Research, Office of Generic Drugs, Office of Research and Standards, U.S. FDA, Silver Spring, Maryland 20993, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Drug Evaluation and Research, Office of Generic Drugs, Office of Research and Standards, U.S. FDA, Silver Spring, Maryland 20993, United States","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048430194","display_name":"Stavros C. Kassinos","orcid":"https://orcid.org/0000-0002-3501-3851","observed_orcids":["https://orcid.org/0000-0002-3501-3851"]},"institutions":[{"id":"https://openalex.org/I34771391","display_name":"University of Cyprus","ror":"https://ror.org/02qjrjx09","country_code":"CY","type":"education","lineage":["https://openalex.org/I34771391"]}],"countries":["CY"],"is_corresponding":false,"raw_author_name":"Stavros Kassinos","raw_affiliation_strings":["University of Cyprus, 1678 Nicosia, Cyprus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cyprus, 1678 Nicosia, Cyprus","institution_ids":["https://openalex.org/I34771391"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007070596","display_name":"Philip J. Kuehl","orcid":"https://orcid.org/0000-0002-7567-3002","observed_orcids":["https://orcid.org/0000-0002-7567-3002"]},"institutions":[{"id":"https://openalex.org/I4210131464","display_name":"Lovelace Medical Center","ror":"https://ror.org/02y4qch95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210131464","https://openalex.org/I4210162315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip J. Kuehl","raw_affiliation_strings":["Lovelace Biomedical, Albuquerque, New Mexico 87108, United States"],"raw_orcid":"https://orcid.org/0000-0002-7567-3002","affiliations":[{"raw_affiliation_string":"Lovelace Biomedical, Albuquerque, New Mexico 87108, United States","institution_ids":["https://openalex.org/I4210131464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026576726","display_name":"David Prime","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Prime","raw_affiliation_strings":["Pulmonary Drug Delivery Consultant, Ware Royston, SG8 7ED, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Drug Delivery Consultant, Ware Royston, SG8 7ED, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030770558","display_name":"Yoen\u2010Ju Son","orcid":"https://orcid.org/0009-0002-5320-6937","observed_orcids":["https://orcid.org/0009-0002-5320-6937"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoen-Ju Son","raw_affiliation_strings":["Genentech, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113991795","display_name":"Simon J. Teague","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Teague","raw_affiliation_strings":["GlaxoSmithKline, Stevenage SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009707322","display_name":"Ulrika Tehler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ulrika Tehler","raw_affiliation_strings":["Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 431 83 Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, 431 83 Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":null,"display_name":"Jennifer Wylie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Wylie","raw_affiliation_strings":["Merck & Co., Inc., Rahway, New Jersey 07065, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, New Jersey 07065, United States","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5013254567"],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":{"value":5000,"currency":"USD","value_usd":5000},"fwci":4.9498,"has_fulltext":true,"cited_by_count":27,"citation_normalized_percentile":{"value":0.96655522,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"21","issue":"1","first_page":"164","last_page":"172"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biopharmaceutics-classification-system","display_name":"Biopharmaceutics Classification System","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pulmonary-drug-delivery","display_name":"pulmonary drug delivery","score":0.6610000133514404},{"id":"https://openalex.org/keywords/lung-deposition","display_name":"lung deposition","score":0.6990000009536743},{"id":"https://openalex.org/keywords/lung-permeability","display_name":"lung permeability","score":0.7829999923706055},{"id":"https://openalex.org/keywords/lung-dose","display_name":"lung dose","score":0.5400000214576721},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.7549999952316284},{"id":"https://openalex.org/keywords/physiologically-based-biopharmaceutics-modeling","display_name":"physiologically based biopharmaceutics modeling","score":0.8600000143051147},{"id":"https://openalex.org/keywords/development-risk","display_name":"development risk","score":0.4169999957084656},{"id":"https://openalex.org/keywords/regional-lung-deposition","display_name":"regional lung deposition","score":0.4320000112056732},{"id":"https://openalex.org/keywords/dissolution","display_name":"dissolution","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.8686599731445312},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5975246429443359},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.5682211518287659},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5274391770362854},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4532058537006378},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.444147527217865},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3941686153411865},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.37874671816825867},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2772384285926819},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.152593731880188},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.0},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000336","descriptor_name":"Aerosols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001702","descriptor_name":"Biopharmaceutics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009330","descriptor_name":"Nebulizers and Vaporizers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.3c00685","doi":"https://doi.org/10.1021/acs.molpharmaceut.3c00685","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.3c00685","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00685","source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10762654","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10762654","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10762654/pdf/mp3c00685.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Pharm","raw_type":"Text"},{"id":"pmid:38059771","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38059771","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1021/acs.molpharmaceut.3c00685","doi":"https://doi.org/10.1021/acs.molpharmaceut.3c00685","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.3c00685","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00685","source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389434864.pdf","grobid_xml":"https://content.openalex.org/works/W4389434864.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1498305210","https://openalex.org/W1801490981","https://openalex.org/W1966640934","https://openalex.org/W1976320079","https://openalex.org/W2010566912","https://openalex.org/W2061622263","https://openalex.org/W2083018626","https://openalex.org/W2111225968","https://openalex.org/W2118762258","https://openalex.org/W2294689490","https://openalex.org/W2489063127","https://openalex.org/W2561079069","https://openalex.org/W2742310794","https://openalex.org/W2769265462","https://openalex.org/W3007383981","https://openalex.org/W3085337735","https://openalex.org/W4280514717","https://openalex.org/W4281487869"],"related_works":["https://openalex.org/W4408413775","https://openalex.org/W4280514717","https://openalex.org/W2294689490","https://openalex.org/W4281487869","https://openalex.org/W4391515246","https://openalex.org/W2112558196","https://openalex.org/W4410778472","https://openalex.org/W1998031288","https://openalex.org/W2182073871","https://openalex.org/W2155451228"],"abstract_inverted_index":{"In":[0],"this":[1],"article,":[2],"we":[3,170],"specify":[4],"for":[5,14,46,188,231,239],"the":[6,32,37,64,69,77,80,83,90,110,119,162,165,172,178,199,204,268],"first":[7],"time":[8],"a":[9,27,93,127,140],"quantitative":[10],"biopharmaceutics":[11,28,101,129,223],"classification":[12,29,102,130,205,234],"system":[13,30,103,131],"orally":[15,20],"inhaled":[16,21,194,226,244,277],"drugs.":[17,245],"To":[18],"date,":[19],"drug":[22,48,72,91,163,208,227,278],"product":[23,53,154,228],"developers":[24],"have":[25,55],"lacked":[26],"like":[31],"one":[33],"developed":[34],"to":[35,60,63,88,125,144,177,191,254,265,273],"navigate":[36],"development":[38,97,155,229],"of":[39,42,66,71,82,98,118,142,161,203,206,242,270],"immediate":[40],"release":[41],"oral":[43],"medicines.":[44],"Guideposts":[45],"respiratory":[47],"discovery":[49],"chemists":[50],"and":[51,58,74,79,149,151,164,181,216,219,237,260,275],"inhalation":[52,84,100,137],"formulators":[54],"been":[56],"elusive":[57],"difficult":[59],"identify":[61,145],"due":[62],"complexity":[65],"pulmonary":[67],"physiology,":[68],"intricacies":[70],"deposition":[73],"disposition":[75],"in":[76],"lungs,":[78],"influence":[81],"delivery":[85],"device":[86],"used":[87],"deliver":[89],"as":[92,139],"respirable":[94],"aerosol.":[95],"The":[96,116,183,201,225],"an":[99,106,271],"(iBCS)":[104],"was":[105,124,186,209],"initiative":[107],"supported":[108],"by":[109,136],"Product":[111],"Quality":[112],"Research":[113],"Institute":[114],"(PQRI).":[115],"goal":[117],"PQRI":[120],"iBCS":[121,173,185,233,272],"working":[122],"group":[123],"generate":[126],"qualitative":[128],"that":[132,250],"can":[133],"be":[134,263],"utilized":[135],"scientists":[138],"\"rule":[141],"thumb\"":[143],"desirable":[146],"molecular":[147],"properties":[148,160],"recognize":[150],"manage":[152],"CMC":[153],"risks":[156],"based":[157,211,222],"on":[158,212],"physicochemical":[159],"deposited":[166],"lung":[167,257],"dose.":[168],"Herein,":[169],"define":[171],"classes":[174,241],"quantitatively":[175],"according":[176],"dose":[179],"number":[180],"permeability.":[182],"proposed":[184],"evaluated":[187],"its":[189],"ability":[190],"categorize":[192],"marketed":[193,243],"drugs":[195],"using":[196],"data":[197],"from":[198],"literature.":[200],"appropriateness":[202],"each":[207,232],"assessed":[210],"published":[213],"development,":[214],"clinical":[215],"nonclinical":[217],"data,":[218],"mechanistic":[220],"physiologically":[221],"modeling.":[224],"challenges":[230],"are":[235],"discussed":[236],"illustrated":[238],"different":[240],"Finally,":[246],"it":[247],"is":[248],"recognized":[249],"discriminatory":[251],"laboratory":[252],"methods":[253],"characterize":[255],"regional":[256],"deposition,":[258],"dissolution,":[259],"permeability":[261],"will":[262],"key":[264],"fully":[266],"realizing":[267],"benefits":[269],"streamline":[274],"derisk":[276],"development.":[279]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-12-08T00:00:00"}